This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Ucb Pharma, S.a., Ucb Biopharma Sprl. Active years: 2013-2019.
Company Filing History:
Years Active: 2013-2019
Title: Frédéric Eeckman: Innovator in Pharmaceutical Formulations
Introduction
Frédéric Eeckman is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prolonged release formulations. With a total of 4 patents to his name, Eeckman's work has had a considerable impact on medication delivery systems.
Latest Patents
Frédéric Eeckman's latest patents include innovative pharmaceutical compositions. One of his notable inventions is a prolonged release formulation comprising an 2-oxo-1-pyrrolidine derivative. This invention specifically relates to a pharmaceutical composition that includes Levetiracetam, Brivaracetam, or Seletracetam as active ingredients. Another significant patent focuses on pharmaceutical compositions comprising Brivaracetam, which also pertains to a prolonged release formulation.
Career Highlights
Throughout his career, Frédéric Eeckman has worked with prominent companies in the pharmaceutical industry. He has been associated with UCB Pharma S.A. and UCB Biopharma Sprl, where he has contributed to various innovative projects. His expertise in pharmaceutical formulations has been instrumental in advancing medication delivery methods.
Collaborations
Frédéric has collaborated with several professionals in his field, including Monique Berwaer and Domenico Fanara. These collaborations have fostered a productive environment for innovation and development in pharmaceutical sciences.
Conclusion
Frédéric Eeckman stands out as a key figure in the realm of pharmaceutical innovations. His contributions through patents and collaborations have significantly advanced the field of prolonged release formulations. His work continues to influence the development of effective medication delivery systems.